Hybrid Nanosystems for Biomedical Applications
Inorganic/organic hybrid nanosystems have been increasingly developed for their versatility and efficacy at overcoming obstacles not readily surmounted by nonhybridized counterparts. Currently, hybrid nanosystems are implemented for gene therapy, drug delivery, and phototherapy in addition to tissue...
Gespeichert in:
Veröffentlicht in: | ACS nano 2021-02, Vol.15 (2), p.2099-2142 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2142 |
---|---|
container_issue | 2 |
container_start_page | 2099 |
container_title | ACS nano |
container_volume | 15 |
creator | Seaberg, Joshua Montazerian, Hossein Hossen, Md Nazir Bhattacharya, Resham Khademhosseini, Ali Mukherjee, Priyabrata |
description | Inorganic/organic hybrid nanosystems have been increasingly developed for their versatility and efficacy at overcoming obstacles not readily surmounted by nonhybridized counterparts. Currently, hybrid nanosystems are implemented for gene therapy, drug delivery, and phototherapy in addition to tissue regeneration, vaccines, antibacterials, biomolecule detection, imaging probes, and theranostics. Though diverse, these nanosystems can be classified according to foundational inorganic/organic components, accessory moieties, and architecture of hybridization. Within this Review, we begin by providing a historical context for the development of biomedical hybrid nanosystems before describing the properties, synthesis, and characterization of their component building blocks. Afterward, we introduce the architectures of hybridization and highlight recent biomedical nanosystem developments by area of application, emphasizing hybrids of distinctive utility and innovation. Finally, we draw attention to ongoing clinical trials before recapping our discussion of hybrid nanosystems and providing a perspective on the future of the field. |
doi_str_mv | 10.1021/acsnano.0c09382 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_crossref_primary_10_1021_acsnano_0c09382</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2481645854</sourcerecordid><originalsourceid>FETCH-LOGICAL-a429t-c35895bfd5cd074bccdcc53eca266c682612e201a6d917e006e6d81810679dee3</originalsourceid><addsrcrecordid>eNp1kM9LwzAUx4Mobk7P3mRHQbolafPrIsyhThh6UfAW0jTVjLapSSvsvzeyOvTg6T143_d5jw8A5wjOEMRornRoVONmUEORcnwAxkikNIGcvh7ue4JG4CSEDYSEcUaPwShNM8GQYGMwW21zb4vpY6SEbehMHaal89Mb62pTWK2q6aJtq9h01jXhFByVqgrmbKgT8HJ3-7xcJeun-4flYp2oDIsu0SnhguRlQXQBWZZrXWhNUqMVplRTjinCBkOkaCEQMxBSQwuOOIKUicKYdAKud9y2z-Mf2jSdV5Vsva2V30qnrPw7aey7fHOfUhCMWJZGwOUA8O6jN6GTtQ3aVJVqjOuDxBlHNCOcZDE630W1dyF4U-7PICi_LcvBshwsx42L39_t8z9aY-BqF4ibcuN630RZ_-K-AHCBiVw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2481645854</pqid></control><display><type>article</type><title>Hybrid Nanosystems for Biomedical Applications</title><source>American Chemical Society</source><source>MEDLINE</source><creator>Seaberg, Joshua ; Montazerian, Hossein ; Hossen, Md Nazir ; Bhattacharya, Resham ; Khademhosseini, Ali ; Mukherjee, Priyabrata</creator><creatorcontrib>Seaberg, Joshua ; Montazerian, Hossein ; Hossen, Md Nazir ; Bhattacharya, Resham ; Khademhosseini, Ali ; Mukherjee, Priyabrata</creatorcontrib><description>Inorganic/organic hybrid nanosystems have been increasingly developed for their versatility and efficacy at overcoming obstacles not readily surmounted by nonhybridized counterparts. Currently, hybrid nanosystems are implemented for gene therapy, drug delivery, and phototherapy in addition to tissue regeneration, vaccines, antibacterials, biomolecule detection, imaging probes, and theranostics. Though diverse, these nanosystems can be classified according to foundational inorganic/organic components, accessory moieties, and architecture of hybridization. Within this Review, we begin by providing a historical context for the development of biomedical hybrid nanosystems before describing the properties, synthesis, and characterization of their component building blocks. Afterward, we introduce the architectures of hybridization and highlight recent biomedical nanosystem developments by area of application, emphasizing hybrids of distinctive utility and innovation. Finally, we draw attention to ongoing clinical trials before recapping our discussion of hybrid nanosystems and providing a perspective on the future of the field.</description><identifier>ISSN: 1936-0851</identifier><identifier>EISSN: 1936-086X</identifier><identifier>DOI: 10.1021/acsnano.0c09382</identifier><identifier>PMID: 33497197</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Drug Delivery Systems ; Phototherapy</subject><ispartof>ACS nano, 2021-02, Vol.15 (2), p.2099-2142</ispartof><rights>2021 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a429t-c35895bfd5cd074bccdcc53eca266c682612e201a6d917e006e6d81810679dee3</citedby><cites>FETCH-LOGICAL-a429t-c35895bfd5cd074bccdcc53eca266c682612e201a6d917e006e6d81810679dee3</cites><orcidid>0000-0002-0557-0833</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acsnano.0c09382$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acsnano.0c09382$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,315,781,785,886,2766,27078,27926,27927,56740,56790</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33497197$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Seaberg, Joshua</creatorcontrib><creatorcontrib>Montazerian, Hossein</creatorcontrib><creatorcontrib>Hossen, Md Nazir</creatorcontrib><creatorcontrib>Bhattacharya, Resham</creatorcontrib><creatorcontrib>Khademhosseini, Ali</creatorcontrib><creatorcontrib>Mukherjee, Priyabrata</creatorcontrib><title>Hybrid Nanosystems for Biomedical Applications</title><title>ACS nano</title><addtitle>ACS Nano</addtitle><description>Inorganic/organic hybrid nanosystems have been increasingly developed for their versatility and efficacy at overcoming obstacles not readily surmounted by nonhybridized counterparts. Currently, hybrid nanosystems are implemented for gene therapy, drug delivery, and phototherapy in addition to tissue regeneration, vaccines, antibacterials, biomolecule detection, imaging probes, and theranostics. Though diverse, these nanosystems can be classified according to foundational inorganic/organic components, accessory moieties, and architecture of hybridization. Within this Review, we begin by providing a historical context for the development of biomedical hybrid nanosystems before describing the properties, synthesis, and characterization of their component building blocks. Afterward, we introduce the architectures of hybridization and highlight recent biomedical nanosystem developments by area of application, emphasizing hybrids of distinctive utility and innovation. Finally, we draw attention to ongoing clinical trials before recapping our discussion of hybrid nanosystems and providing a perspective on the future of the field.</description><subject>Drug Delivery Systems</subject><subject>Phototherapy</subject><issn>1936-0851</issn><issn>1936-086X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM9LwzAUx4Mobk7P3mRHQbolafPrIsyhThh6UfAW0jTVjLapSSvsvzeyOvTg6T143_d5jw8A5wjOEMRornRoVONmUEORcnwAxkikNIGcvh7ue4JG4CSEDYSEcUaPwShNM8GQYGMwW21zb4vpY6SEbehMHaal89Mb62pTWK2q6aJtq9h01jXhFByVqgrmbKgT8HJ3-7xcJeun-4flYp2oDIsu0SnhguRlQXQBWZZrXWhNUqMVplRTjinCBkOkaCEQMxBSQwuOOIKUicKYdAKud9y2z-Mf2jSdV5Vsva2V30qnrPw7aey7fHOfUhCMWJZGwOUA8O6jN6GTtQ3aVJVqjOuDxBlHNCOcZDE630W1dyF4U-7PICi_LcvBshwsx42L39_t8z9aY-BqF4ibcuN630RZ_-K-AHCBiVw</recordid><startdate>20210223</startdate><enddate>20210223</enddate><creator>Seaberg, Joshua</creator><creator>Montazerian, Hossein</creator><creator>Hossen, Md Nazir</creator><creator>Bhattacharya, Resham</creator><creator>Khademhosseini, Ali</creator><creator>Mukherjee, Priyabrata</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0557-0833</orcidid></search><sort><creationdate>20210223</creationdate><title>Hybrid Nanosystems for Biomedical Applications</title><author>Seaberg, Joshua ; Montazerian, Hossein ; Hossen, Md Nazir ; Bhattacharya, Resham ; Khademhosseini, Ali ; Mukherjee, Priyabrata</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a429t-c35895bfd5cd074bccdcc53eca266c682612e201a6d917e006e6d81810679dee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Drug Delivery Systems</topic><topic>Phototherapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Seaberg, Joshua</creatorcontrib><creatorcontrib>Montazerian, Hossein</creatorcontrib><creatorcontrib>Hossen, Md Nazir</creatorcontrib><creatorcontrib>Bhattacharya, Resham</creatorcontrib><creatorcontrib>Khademhosseini, Ali</creatorcontrib><creatorcontrib>Mukherjee, Priyabrata</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>ACS nano</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Seaberg, Joshua</au><au>Montazerian, Hossein</au><au>Hossen, Md Nazir</au><au>Bhattacharya, Resham</au><au>Khademhosseini, Ali</au><au>Mukherjee, Priyabrata</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hybrid Nanosystems for Biomedical Applications</atitle><jtitle>ACS nano</jtitle><addtitle>ACS Nano</addtitle><date>2021-02-23</date><risdate>2021</risdate><volume>15</volume><issue>2</issue><spage>2099</spage><epage>2142</epage><pages>2099-2142</pages><issn>1936-0851</issn><eissn>1936-086X</eissn><abstract>Inorganic/organic hybrid nanosystems have been increasingly developed for their versatility and efficacy at overcoming obstacles not readily surmounted by nonhybridized counterparts. Currently, hybrid nanosystems are implemented for gene therapy, drug delivery, and phototherapy in addition to tissue regeneration, vaccines, antibacterials, biomolecule detection, imaging probes, and theranostics. Though diverse, these nanosystems can be classified according to foundational inorganic/organic components, accessory moieties, and architecture of hybridization. Within this Review, we begin by providing a historical context for the development of biomedical hybrid nanosystems before describing the properties, synthesis, and characterization of their component building blocks. Afterward, we introduce the architectures of hybridization and highlight recent biomedical nanosystem developments by area of application, emphasizing hybrids of distinctive utility and innovation. Finally, we draw attention to ongoing clinical trials before recapping our discussion of hybrid nanosystems and providing a perspective on the future of the field.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>33497197</pmid><doi>10.1021/acsnano.0c09382</doi><tpages>44</tpages><orcidid>https://orcid.org/0000-0002-0557-0833</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1936-0851 |
ispartof | ACS nano, 2021-02, Vol.15 (2), p.2099-2142 |
issn | 1936-0851 1936-086X |
language | eng |
recordid | cdi_crossref_primary_10_1021_acsnano_0c09382 |
source | American Chemical Society; MEDLINE |
subjects | Drug Delivery Systems Phototherapy |
title | Hybrid Nanosystems for Biomedical Applications |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T21%3A56%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hybrid%20Nanosystems%20for%20Biomedical%20Applications&rft.jtitle=ACS%20nano&rft.au=Seaberg,%20Joshua&rft.date=2021-02-23&rft.volume=15&rft.issue=2&rft.spage=2099&rft.epage=2142&rft.pages=2099-2142&rft.issn=1936-0851&rft.eissn=1936-086X&rft_id=info:doi/10.1021/acsnano.0c09382&rft_dat=%3Cproquest_pubme%3E2481645854%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2481645854&rft_id=info:pmid/33497197&rfr_iscdi=true |